A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
O'Neil, B. H., Scott, A. J., Ma, W. W., Cohen, S. J., Leichman, L., Aisner, D. L., Menter, A. R., Tejani, M. A., Cho, J. K., Granfortuna, J., Coveler, L., Olowokure, O. O., Baranda, J. C., Cusnir, M.,Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv477
Date:
October, 2015
File:
PDF, 28 KB
english, 2015
File converter
More search results
More benefits 
